Overview · Filed: —
ACT_551308/2023
A SYSTEM COMPRISING A PROSTHETIC VALVE AND A DELIVERY CATHETER
RevocationMain Revocation ActionParis CDRevocation Action—
Parties
Claimants
- Meril Italy S.r.l.(Meril Group)
- Meril GmbH(Meril Group)
- Meril Life Sciences Pvt Ltd.(Meril Group)
Reps: Emmanuel Larere (Cabinet Gide Loyrette Nouel AARPI); Raphaëlle Dequiré-Portier (Cabinet Gide Loyrette Nouel AARPI); Jean-Robert Callon de Lamarck (Cabinet Regimbeau); Jonathan Stafford (Marks & Clerk LLP); Andreas von Falck (Hogan Lovells International LLP)
Respondents
- Edwards Lifesciences Corporation(Edwards Lifesciences Group)
Reps: Boris Kreye (Bird & Bird LLP); Elsa Tzschoppe (Bird & Bird LLP); Bernhard Thum (Thum & Partner); Jonas Weickert (Thum & Partner); Siddharth Kusumakar (Powell Gilbert (Europe) LLP); Tessa Waldron (Powell Gilbert (Europe) LLP); Bryce Matthewson (Powell Gilbert (Europe) LLP)
Judges
French-seated division — individual judges anonymized.
- Panel member (anonymized)Presiding Judge and Judge-rapporteur
- Panel member (anonymized)Legally Qualified Judge
- Panel member (anonymized)Technically Qualified Judge
Patents
- EP3646825
CPC codes: A61F2220/0075, A61F2/2436, A61F2250/0065, A61F2/2418, A61F2230/0054, A61F2250/0069, A61F2/2433
Technology area: Medical Devices · Implants
Sector: Pharmaceutical & Medical
Outcome
Patent amendedMaintained as amended
Filed: —
First decided: Jul 19, 2024
Language: —
The Paris Central Division rejected the revocation actions filed by Meril Italy Srl and Meril GmbH/Meril Life Sciences Pvt Ltd against EP 3 646 825, maintaining the patent in amended form as per auxiliary request II submitted during the proceedings; costs were split 60% (claimants/counterclaimants) and 40% (defendant).
Claims
At issueall
Amendedall
Notes: Patent EP3646825 maintained in amended form per auxiliary request II (frame made up entirely of hexagonal cells); revocation actions by both claimant and counterclaimants rejected; no specific claim numbers other than claim 1 enumerated in excerpts.